C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 215/54 (2006.01) A61K 31/47 (2006.01) A61P 35/00 (2006.01) C07D 215/56 (2006.01)
Patent
CA 2467573
This invention provides compounds of Formula (I), represented by the structure wherein G1, G2, G3, G4, Z, X and n are defined herein, or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of polycystic kidney disease.
L'invention concerne des composés de formule (I), représentés par la structure dans laquelle G¿1?, G¿2?, G¿3?, G¿4?, Z, X et n sont définis dans la description, ou un sel de ces composés, acceptable sur le plan pharmaceutique, qui sont utiles en tant qu'agents antitumoraux et dans le traitement de maladie polykystique des reins.
Floyd Middleton Brawner Jr.
Johnson Bernard Dean
Overbeek-Klumpers Elsebe Geraldine
Tsou Hwei-Ru
Wissner Allan
Torys Llp
Wyeth Holdings Corporation
LandOfFree
3-cyanoquinolines as inhibitors of egf-r and her2 kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-cyanoquinolines as inhibitors of egf-r and her2 kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-cyanoquinolines as inhibitors of egf-r and her2 kinases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1821328